Enlivex Therapeutics Ltd. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Enlivex Therapeutics Ltd. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 20.9M shares, a 12.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 20.9M +2.29M +12.3% Jun 30, 2024 6-K 2024-08-30
Q4 2023 18.6M +177K +0.96% Dec 31, 2023 6-K 2024-08-30
Q2 2023 18.6M +208K +1.13% Jun 30, 2023 6-K 2023-09-01
Q4 2022 18.4M +90.3K +0.49% Dec 31, 2022 20-F 2024-04-30
Q2 2022 18.4M +74.9K +0.41% Jun 30, 2022 6-K 2022-08-22
Q4 2021 18.3M +3.74M +25.7% Dec 31, 2021 20-F 2023-04-10
Q2 2021 18.3M +4.84M +36% Jun 30, 2021 6-K 2021-08-06
Q4 2020 14.6M +4.25M +41.2% Dec 31, 2020 20-F 2022-04-29
Q2 2020 13.5M Jun 30, 2020 6-K/A 2020-10-13
Q1 2020 2.09M Mar 5, 2020 6-K/A 2020-10-13
Q4 2019 10.3M +6.82M +194% Dec 31, 2019 20-F 2021-04-30
Q4 2018 3.51M +3.09M +739% Dec 31, 2018 20-F 2020-04-30
Q4 2017 418K -2.86M -87.2% Dec 31, 2017 20-F/A 2020-01-23
Q4 2016 3.28M -11M -77% Dec 31, 2016 20-F 2018-04-23
Q4 2015 14.2M 0 0% Dec 31, 2015 20-F 2017-02-24
Q4 2014 14.2M +5.05M +55% Dec 31, 2014 20-F 2016-03-29
Q4 2013 9.18M Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.